Active TopicsActive Topics  Display List of Forum MembersMemberlist  CalendarCalendar  Search The ForumSearch  HelpHelp
  RegisterRegister  LoginLogin

Sector talk
 The Equity Desk Forum :Investment Ideas - Creating winning portfolios! :Sector talk
Message Icon Topic: MNC Stocks - Safety vs. Growth. Post Reply Post New Topic
<< Prev Page  of 4 Next >>
Author Message
Ajith
Senior Member
Senior Member
Avatar

Joined: 06/Aug/2006
Location: India
Online Status: Offline
Posts: 1284
Quote Ajith Replybullet Posted: 12/Apr/2008 at 11:08am
Nowadays, I love MNCs not the firangis but the the India--based ones because of delisting possibilities though there may be exceptions.


Edited by Ajith - 13/Apr/2008 at 1:19pm
Ajith
IP IP Logged
bassein
Senior Member
Senior Member


Joined: 14/Apr/2008
Location: India
Online Status: Offline
Posts: 216
Quote bassein Replybullet Posted: 24/Aug/2008 at 8:42pm
Since Novartis has been mentioned in this thread, here's a slightly old cut-and-paste:

Reliance MF doubts Novartis' inter-group deals
14 Aug, 2008, 0600 hrs IST,Deeptha Rajkumar, ET Bureau

MUMBAI: In an unusual case of shareholder activism by a fund house, the country’s largest mutual fund (MF), Reliance MF, which holds close to 5% equity in Novartis India, has raised certain corporate governance issues, especially those relating to inter-group transactions by the pharma company.

Novartis India has inter-corporate deposits outstanding from its group companies to the tune of Rs 340 crore — as of March 2008 — which constitutes almost 76% of the company’s net worth. Under related party disclosures during the year, close to Rs 2,457 crore worth of loan transactions have been carried out with group firms.

According to sources familiar with the development, the asset management company has raised queries as to why group companies are being supported with cheap capital by Novartis. It sought clarity from the company management on the rates at which such loans have been advanced. A related issue flagged off is that if the pharma firm is not in need of surplus cash to grow its core business, then the company would be better-off by ensuring a payout in the form of higher dividends to shareholders.

The other concern expressed by Reliance MF is that if a large part of the company’s net worth is deployed in financing activities, there could be the risk of the firm being liable to be registered as a non-banking finance company (NBFC) with the Reserve Bank of India.

It is learnt that the mutual fund even raised some of these issues at the company’s last AGM. Shareholders with more than 1% stake in Novartis India are LIC (5.67%), Azim Premji (2.53%), Bajaj Allianz Life Insurance (2.72%) and GIC (1.61%), among others.



The company is understood to have questioned whether shareholders’ approval was taken to give such huge loans. It also sought information about the securities pledged by the borrowers. When contacted, a Novartis spokesperson said the company has already met representatives of Reliance Mutual Fund and clarified all the issues.

“Full disclosures have been made in our annual report of 2007-08 with regard to the inter-corporate deposits referred to by you and these have also been duly audited. Surplus funds of Novartis India are deployed on an arm’s length basis to 100% subsidiaries of the Novartis Group at market-related rate of interest and in full compliance with the applicable provisions of the Companies Act, 1956. These funds are available to Novartis India on call in case of business need or opportunity,” a Novartis company spokesperson told ET. Reliance Mutual Fund officials were unavailable for comment.

Regarding the issue of rental income received from group companies falling significantly, Novartis clarified that this could be attributed to the fact that group companies have moved out of Novartis India premises to larger ones elsewhere and the vacant premises have been rented out to a third party. Novartis India scrip ended 2.75% lower at Rs 302.50 on BSE on Wednesday.

IP IP Logged
rapidriser
Senior Member
Senior Member
Avatar

Joined: 18/Nov/2007
Location: India
Online Status: Offline
Posts: 966
Quote rapidriser Replybullet Posted: 24/Aug/2008 at 10:34pm
Originally posted by bassein

Since Novartis has been mentioned in this thread, here's a slightly old cut-and-paste:

Reliance MF doubts Novartis' inter-group deals
14 Aug, 2008, 0600 hrs IST,Deeptha Rajkumar, ET Bureau

MUMBAI: In an unusual case of shareholder activism by a fund house, the country’s largest mutual fund (MF), Reliance MF, which holds close to 5% equity in Novartis India, has raised certain corporate governance issues, especially those relating to inter-group transactions by the pharma company.

 
Wonder if they will pose the same questions to Reliance & ADAG group companies where such transactions run into tens of thousand crore rupees.
IP IP Logged
bassein
Senior Member
Senior Member


Joined: 14/Apr/2008
Location: India
Online Status: Offline
Posts: 216
Quote bassein Replybullet Posted: 25/Aug/2008 at 3:41pm
Originally posted by rapidriser

Originally posted by bassein

Since Novartis has been mentioned in this thread, here's a slightly old cut-and-paste:

Reliance MF doubts Novartis' inter-group deals
14 Aug, 2008, 0600 hrs IST,Deeptha Rajkumar, ET Bureau

MUMBAI: In an unusual case of shareholder activism by a fund house, the country’s largest mutual fund (MF), Reliance MF, which holds close to 5% equity in Novartis India, has raised certain corporate governance issues, especially those relating to inter-group transactions by the pharma company.

 
Wonder if they will pose the same questions to Reliance & ADAG group companies where such transactions run into tens of thousand crore rupees.


Not to forget the multiple offices registered at the same address.Wink
IP IP Logged
Vivek Sukhani
Senior Member
Senior Member
Avatar

Joined: 23/Jul/2006
Online Status: Offline
Posts: 6675
Quote Vivek Sukhani Replybullet Posted: 18/Apr/2009 at 10:47am
Some of the MNCs are now poised to leapfrog into growth category. My names in that list will be:
 
1.Vesuvius India
2.Foseco india
3.Glaxo SmithKline Consumer
4.3M India
5.Bayer Cropsciences
6.Bata India
7.Hitachi Home
8.DIC India
9.BASF India
10.Siemens Medical
Jai Guru!!!
IP IP Logged
subu76
Senior Member
Senior Member


Joined: 25/Feb/2008
Online Status: Offline
Posts: 5709
Quote subu76 Replybullet Posted: 18/Apr/2009 at 11:48am
Hi Vivek, Could you please elaborate on your thoughts around Bata's growth?  Their top line has remained flattish over the last 5 years. Is there any strategic move (like Reliance deal) which will help perk up their numbers?
IP IP Logged
Vivek Sukhani
Senior Member
Senior Member
Avatar

Joined: 23/Jul/2006
Online Status: Offline
Posts: 6675
Quote Vivek Sukhani Replybullet Posted: 19/Apr/2009 at 12:12pm

Read this:

 
Apart from this, Bata is a very solid brand at least in Eastern india and especially in calcutta. This company is a leader in branded footwear segment and is tapping newer and less capital intensive avenues. Its more like a titan, available at a better valuation, and in a sector which is less discretionary in nature compared to watches.
Jai Guru!!!
IP IP Logged
subu76
Senior Member
Senior Member


Joined: 25/Feb/2008
Online Status: Offline
Posts: 5709
Quote subu76 Replybullet Posted: 19/Apr/2009 at 12:43pm
Thanks for sharing your thoughts.
IP IP Logged
<< Prev Page  of 4 Next >>
Post Reply Post New Topic
Printable version Printable version

Forum Jump
You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot delete your posts in this forum
You cannot edit your posts in this forum
You cannot create polls in this forum
You cannot vote in polls in this forum



This page was generated in 0.016 seconds.
Bookmark this Page